OR WAIT null SECS
© 2022 MJH Life Sciences and BioPharm International. All rights reserved.
© 2022 MJH Life Sciences™ and BioPharm International. All rights reserved.
175 Crossing Blvd.
Harry M. Meade, PhD, is senior vice president of research and development at GTC Biotherapeutics, Inc.
Capital investments in production plants represent a significant portion of the cost of new recombinant drugs